REQUEST A DEMO
Total
USD $0.00
Search more companies

Rudraksh Psyllium Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Rudraksh Psyllium Private Limited Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Rudraksh Psyllium Private Limited is an enterprise in India, with the main office in Jodhpur. It operates in the Pharmaceutical and Medicine Manufacturing industry. The company was established on February 12, 2011. In its most recent financial highlights, the company reported a net sales revenue increase of 23.06% in 2024. During that time, Rudraksh Psyllium Private Limited’s total assets grew by 16.7%. The net profit margin of Rudraksh Psyllium Private Limited increased by 0.19% in 2024.

Legal Address
Khasra No: 1006/1, Jodhpur Road, Village Post: Riyan
Jodhpur; Rajasthan; Postal Code: 342601

Contact Details: Purchase the Rudraksh Psyllium Private Limited report to view the information.

Basic Information
Registered Capital:
Purchase the Rudraksh Psyllium Private Limited report to view the information.
Financial Auditors:
Purchase the Rudraksh Psyllium Private Limited report to view the information.
Incorporation Date:
February 12, 2011
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Professional Director
Company Performance
Financial values in the chart are available after Rudraksh Psyllium Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
23.06%
Total Operating Revenue
23.05%
Operating Profit
19.52%
EBITDA
16.92%
Net Profit/Loss for the Period
66.56%
Total Assets
16.7%
Total Equity
2.28%
Operating Profit Margin
-0.41%
Net Profit Margin
0.19%
Return on Equity (ROE)
0.86%
Debt / Equity
22%
Quick Ratio
0.09%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?